A detailed history of Healthcare Of Ontario Pension Plan Trust Fund transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Healthcare Of Ontario Pension Plan Trust Fund holds 843,300 shares of TVTX stock, worth $15.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
843,300
Previous 615,000 37.12%
Holding current value
$15.6 Million
Previous $5.06 Million 133.37%
% of portfolio
0.03%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.89 - $15.21 $1.8 Million - $3.47 Million
228,300 Added 37.12%
843,300 $11.8 Million
Q2 2024

Aug 14, 2024

BUY
$5.26 - $8.28 $2.17 Million - $3.41 Million
412,000 Added 202.96%
615,000 $5.06 Million
Q1 2024

May 13, 2024

SELL
$7.18 - $9.82 $3.1 Million - $4.24 Million
-432,277 Reduced 68.05%
203,000 $1.57 Million
Q4 2023

Mar 21, 2024

BUY
$5.44 - $9.5 $3.46 Million - $6.04 Million
635,277 New
635,277 $5.71 Million
Q1 2023

May 12, 2023

SELL
$17.82 - $22.89 $11.1 Million - $14.3 Million
-623,000 Reduced 71.04%
254,000 $5.71 Million
Q4 2022

Feb 13, 2023

BUY
$18.47 - $26.14 $2.23 Million - $3.16 Million
121,000 Added 16.01%
877,000 $18.4 Million
Q3 2022

Nov 14, 2022

BUY
$22.91 - $28.63 $10.2 Million - $12.8 Million
445,500 Added 143.48%
756,000 $18.6 Million
Q2 2022

Aug 11, 2022

BUY
$20.94 - $30.01 $1.99 Million - $2.85 Million
95,000 Added 44.08%
310,500 $7.52 Million
Q1 2022

May 12, 2022

SELL
$23.61 - $30.6 $7.38 Million - $9.56 Million
-312,500 Reduced 59.19%
215,500 $5.55 Million
Q4 2021

Feb 11, 2022

BUY
$24.34 - $31.17 $6.29 Million - $8.05 Million
258,400 Added 95.85%
528,000 $16.4 Million
Q3 2021

Nov 10, 2021

SELL
$12.98 - $25.03 $31,152 - $60,072
-2,400 Reduced 0.88%
269,600 $6.54 Million
Q2 2021

Aug 12, 2021

BUY
$14.11 - $26.4 $3.84 Million - $7.18 Million
272,000 New
272,000 $3.97 Million

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.19B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.